NCT01131910 TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs Status COMPLETED Phase PHASE2
NCT01126541 SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy Status COMPLETED Phase PHASE3
NCT01123655 Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients Status COMPLETED Phase PHASE1
NCT01120366 Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation Status COMPLETED Phase PHASE4
NCT01119859 A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT01117129 A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR) Status TERMINATED Phase PHASE4
NCT01116141 A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT01111357 Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01106560 A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement Status COMPLETED Phase NA
NCT01105715 Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01102829 Early Migration in a High Congruent Rotating Platform Total Knee Prosthesis Design Status COMPLETED Phase N/A
NCT01098201 Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) Status COMPLETED Phase N/A
NCT01096069 Complement Regulatory Proteins Expression and Clinical Response in Rheumatoid Arthritis (RA) Patients Treated With Rituximab Status UNKNOWN Phase N/A
NCT01095393 National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) Status COMPLETED Phase N/A
NCT01090570 Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate Status WITHDRAWN Phase PHASE1
NCT01089023 A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT01088360 Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) Status ACTIVE_NOT_RECRUITING Phase N/A